Combined blood markers correctly detect early pancreatic cancer in human cancer cells
A newly identified biomarker panel could pave the way to earlier detection and better treatment for pancreatic cancer, according to new research from the Perelman School of Medicine at University of Pennsylvania. Currently over 53,000 people in the United States are diagnosed with pancreatic cancer — the fourth leading cause of cancer death — every year. The blood biomarkers, detailed today in Science Translational Medicine, correctly detected pancreatic cancer in blood samples from patients at different stages of their disease.
The majority of pancreatic cancer patients are not diagnosed until an advanced stage, beyond the point at which their tumors can be surgically removed.
A team led by Ken Zaret, PhD, director of the Penn Institute for Regenerative Medicine and the Joseph Leidy Professor of Cell and Developmental Biology, and Gloria Petersen, PhD, from the Mayo Clinic, identified a pair of biomarkers that physicians could soon use to discover the disease earlier.
“Starting with our cell model that mimics human pancreatic cancer progression, we identified released proteins, then tested and validated a subset of these proteins as potential plasma biomarkers of this cancer,” Zaret said. The authors anticipate that health care providers will use the early-detection biomarkers to test for their presence and levels in blood from pancreatic cancer patients and blood drawn from individuals with a high risk of developing pancreatic cancer, including those who have a first-degree relative with pancreatic cancer, are genetically predisposed to the disease, or who had a sudden onset of diabetes after the age of 50.
“Early detection of cancer has had a critical influence on lessening the impact of many types of cancer, including breast, colon, and cervical cancer. A long standing concern has been that patients with pancreatic cancer are often not diagnosed until it is too late for the best chance at effective treatment,” said Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center (ACC) at the University of Pennsylvania. “Having a biomarker test for this disease could dramatically alter the outlook for these patients.”
Novel method for discovering pancreatic cancer biomarkers
Credit: The lab of Ken Zaret, Perelman School of Medicine, University of Pennsylvania
The biomarker panel, enabled by discovery work of first author Jungsun Kim, PhD, a postdoctoral fellow in Zaret’s lab, builds on a first-of-its-kind human-cell model of pancreatic cancer progression the lab described in 2013. They used stem-cell technology to create a cell line from a patient with advanced pancreatic ductal adenocarcinoma. Genetically reprogramming late-stage human cancer cells to a stem-cell state enabled them to force the reprogrammed cells to progress to an early cancerous state, revealing secreted blood biomarkers of early-stage disease along the way.
The best candidate biomarker, plasma thrombospondin-2 (THBS2), was screened against 746 cancer and control plasma samples using an inexpensive, commercially available protein-detection assay. The team found that blood levels of THBS2, combined with levels of a known later-stage biomarker called CA19-9, was reliable at detecting the presence of pancreatic cancer in patients.
The team refined the assay with independent investigations of plasma samples from patients with different stages of cancer, from individuals with benign pancreatic disease, and from healthy controls, all obtained from Petersen, who directs the biospecimen resource program for pancreas research at the Mayo Clinic.
“Positive results for THBS2 or CA19-9 concentrations in the blood consistently and correctly identified all stages of the cancer,” Zaret said. “Notably, THBS2 concentrations combined with CA19-9 identified early stages better than any other known method.” The combination panel also improved the ability to distinguish cases of cancer from pancreatitis. The panel will next be validated in a set of samples from pancreatic cancer patients who provided a research blood sample prior to their diagnosis.
The Latest on: Pancreatic cancer
[google_news title=”” keyword=”pancreatic cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Pancreatic Cancer Therapeutics & Diagnostics Market and its Economic Impact on Industry : Growth And Trend 2028on February 7, 2023 at 10:00 pm
Final Report will add an analysis of the impact of the Russia-Ukraine War and COVID-19 on thePancreatic Cancer ...
- UC researcher aims to develop better treatments for KRAS-mutated pancreatic canceron February 7, 2023 at 6:41 pm
Pancreatic cancer diagnoses are increasing more rapidly than any other cancer type while remaining one of the most deadly cancers.
- Pancreatic cancer cells found to contain high levels of hydrogen peroxideon February 7, 2023 at 7:06 am
Reactive oxygen species (ROS) are reputed for their involvement in carcinogenesis. Results from a study published in the journal Angewandte Chemie have now shown that the level of one such ROS, ...
- Doctors Say These are the Signs of Pancreatic Canceron February 7, 2023 at 4:01 am
There are people who beat the odds, but pancreatic cancer is difficult to diagnose. Read on to ensure your health.
- Making pancreatic cancer treatments more effectiveon February 6, 2023 at 4:00 pm
The National Cancer Institute (NCI) has announced an intent to fund research from the University of Cincinnati’s Andrew Waters, PhD, to better understand how to overcome treatment resistance and ...
- Pancreatic cancer clinical trial opens in Queensland, offering hope to patientson February 5, 2023 at 4:52 pm
The treatment, which is already being trialled in Melbourne and Sydney, aims to break down the tissue that shields pancreatic cancer cells from the immune system, allowing chemotherapy to be more ...
- Influencer fingió tener cáncer terminal y recaudó miles de dólareson February 3, 2023 at 5:45 pm
La joven pidió donativos por un supuesto cáncer de páncreas que debía tratar y reunió gracias a GoFound más de 37 mil dólares (unos 700 mil pesos mexicanos) ...
- Comience su tratamiento contra el cáncer más rápidamente mediante el servicio de Diagnóstico Rápido de MSKon February 1, 2023 at 9:00 pm
El día antes de Acción de Gracias, Mary Oehrlein recibió la noticia demoledora. Se había hecho algunas pruebas en un hospital local para averiguar la causa de sus problemas estomacales. Cuando recibió ...
- 14 síntomas de cáncer de páncreas que son fáciles de ignoraron January 27, 2023 at 9:58 am
Si tiene indigestión y dolor de estómago, y tal vez no ha comido y se siente un poco enfermo, podría pensar que solo tiene un virus estomacal. Y si bien esa es, por mucho, la causa más probable, tenga ...
- 14 síntomas de cáncer de páncreas que pueden pasar desapercibidoson January 27, 2023 at 9:58 am
Una enfermera especialista en cáncer de páncreas describe los signos de la enfermedad fáciles de ignorar Si tienes indigestión y dolor de estómago, y tal vez no has comido y se sientes un poco enfermo ...
via Google News and Bing News